Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Europe Cannabis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type; Application; Compound, and Country" report has been added to ResearchAndMarkets.com's offering.
The Europe cannabis market is expected to reach US$ 36,997.1 million by 2027 from US$ 3,498.1 million in 2019; it is anticipated to grow at a CAGR of 29.6% from 2020 to 2027.
The growth of the market in this region is attributed to the upgrading of regulations for medical cannabis and growth of the cannabis industry. However, challenges related to cannabis hinder the market growth.
The European countries are experiencing transformation in the regulations for marketing cannabis and related products. The changes in the regulations have allowed the cultivation, processing, and trade of the cannabis-derived products across this region. In addition, the online distribution of CBD has received more attention, and companies are emerging at a faster rate.
In May 2019, European Cannabis Holding (ECH) and Miller & Miller Chemicals Ltd. formed Astral Health, a new end-to-end platform, in the UK to import approved medical cannabis products. In the following weeks of May, countries such as Germany, Italy, Spain, and France were expected to announce the distribution of cannabis medical products.
There has been a significant rise in startups in the European cannabis market in the past few years. For instance, Blossom Genetics, Cannamedical Pharma, Demecan, Grass & Co, Cannaray, Rainbow, NOBL Group, Alphagreen, Sanity Group, and Daye were founded after 2015. Moreover, well-established companies are launching new products in the market. For instance, in December 2019, EMMAC Life Sciences Group launched its first unlicensed medical cannabis products in the UK and European market.
According to a report by the UN's International Narcotics Control Board, before legalization, the UK has emerged as the largest producer and exporter of legalized cannabis for medical and research applications. Therefore, it is expected that the legalization of cannabis in the European region would further enhance the UK's cannabis industry.
In April, 2020, a study posted on Pan European Networks Ltd, a health European website, stated that the researchers would conduct an anonymous survey among medical cannabis patients regarding their mental health and physical health, as well as examining changes in patient's frequency of use of cannabis, dosage, and route of administration based on COVID-19-realted closures and updates. Thus, it is expected that the COVID-19 pandemic is likely to offer extensive growth opportunities for market growth.
Based on product type, the Europe cannabis market is segmented into flowers, concentrates, and others. In 2019, the flowers held the largest market share; however, the concentrates segment is expected to witness the highest CAGR during the forecast period. Based on application, the European cannabis market is segmented into medical and recreational.
In 2019, the medical segment held a larger share of the market; however, the recreational segment is anticipated to register a higher CAGR in the market during 2020-2027. Based on compound, the Europe cannabis market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC and CBD. In 2019, the THC dominant segment held the largest share of the market. However, the market for the CBD dominant segment is estimated to grow at the highest CAGR during the forecast period.
The European Food Safety Authority, European Monitoring Centre for Drugs and Drug Addiction, and International Cannabis and Cannabinoids Institute are among the major primary and secondary sources associated with this study on the Europe cannabis market report.
Key Topics Covered:
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
2. Cannabis Market - Key Takeaways
3. Research Methodology
3.2 Secondary Research
3.3 Primary Research
4. Cannabis - Market Landscape
4.2 PEST Analysis
4.3 Expert Opinion
5. Europe Cannabis Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Up-gradation of Regulations for Medical Cannabis
5.1.2 Growing Cannabis Industry
5.2 Key Market Restraints
5.2.1 Challenges Related to Cannabis
5.3 Key Market Opportunities
5.3.1 Rising Market Consolidations
5.4 Future Trends
5.4.1 Growing Acceptance of Cannabis Products
5.5 Impact Analysis
6. Cannabis Market - Regional Analysis
6.1 Europe Cannabis Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Cannabis Market Analysis - By Product Type
7.2 Cannabis Market Revenue Share, by Product Type, 2019 and 2027 (%)
7.2.1 Europe Cannabis Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
7.3 Flowers Market
7.4 Concentrates Market
7.5 Others Market
8. Cannabis Market - By Application
8.2 Cannabis Market, by Application, 2019 and 2027 (%)
8.2.1 Europe Cannabis Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.3 Medical Market
8.3.2 Medical Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Pain Management
8.3.4 Neurological Health Management
8.3.5 Mental Health Management
8.4 Recreational Market
9. Cannabis Market - By Compound
9.2 Cannabis Market, by Compound, 2019 and 2027 (%)
9.2.1 Europe Cannabis Market, by Compound - Revenue and Forecast to 2027 (USD Million)
9.3 Tetrahydrocannabinol (THC)-Dominant Market
9.4 Cannabidiol (CBD)-Dominant Market
9.5 Balanced THC and CBD Market
10. Cannabis Market- Regional Analysis
11. Impact of COVID-19 Pandemic on Europe Cannabis Market
12. Cannabis Market-Key Company Profiles
Cannabis Science, Inc.
Canopy Growth Corporation
Medical Marijuana, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/z1z80d
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900